We are live on
!
Find out more
Schroder Investment Management Group Portfolio holdings
AUM
$141B
1-Year Est. Return
34.18%
This Fund
S&P 500
This Quarter
Est. Return
+16.28%
1 Year Est. Return
+34.18%
3 Year Est. Return
+121.7%
5 Year Est. Return
+159.58%
10 Year Est. Return
+614.8%
AUM
$118B
AUM Growth
+$19.3B
(+19%)
Cap. Flow
+$6.2B
Cap. Flow
% of AUM
5.24%
Top 10 Holdings %
Top 10 Hldgs %
30.96%
Holding
1,252
New
68
Increased
498
Reduced
525
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$961M |
| 2 |
Monster Beverage
MNST
|
+$436M |
| 3 |
Colgate-Palmolive
CL
|
+$344M |
| 4 |
NVIDIA
NVDA
|
+$339M |
| 5 |
Salesforce
CRM
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$474M |
| 2 |
lululemon athletica
LULU
|
+$409M |
| 3 |
UnitedHealth
UNH
|
+$359M |
| 4 |
Spotify
SPOT
|
+$217M |
| 5 |
Procter & Gamble
PG
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.09% |
| 2 | Communication Services | 13.6% |
| 3 | Financials | 13.17% |
| 4 | Consumer Discretionary | 11.14% |
| 5 | Healthcare | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Lockheed Martin
LMT
$131B
| $5.71M | ﹤0.01% |
12,334
-560
| -4% | -$262K |
|
727
Janux Therapeutics
JANX
$1.15B
| $5.7M | ﹤0.01% |
246,916
+54,544
| +28% | +$1.44M |
|
728
Ford
F
$55.6B
| $5.7M | ﹤0.01% |
525,343
+31,945
| +6% | +$325K |
|
729
Reliance Steel & Aluminium
RS
$20B
| $5.69M | ﹤0.01% |
18,122
-11,445
| -39% | -$3.38M |
|
|
LX
730
LexinFintech Holdings
LX
$191M
| $5.68M | ﹤0.01% |
788,258
-134,835
| -15% | -$1.05M |
|
731
Assured Guaranty
AGO
$3.34B
| $5.67M | ﹤0.01% |
65,085
-2,020
| -3% | -$172K |
|
732
Fidelity National Information Services
FIS
$20.9B
| $5.48M | ﹤0.01% |
67,284
-520,164
| -89% | -$40.5M |
|
733
Dominion Energy
D
$58.5B
| $5.47M | ﹤0.01% |
96,820
-369,263
| -79% | -$20.2M |
|
734
Griffon
GFF
$4.49B
| $5.43M | ﹤0.01% |
75,052
-666
| -0.9% | -$46.4K |
|
735
UGI
UGI
$8.2B
| $5.43M | ﹤0.01% |
+149,111
| New | +$5.13M |
|
736
Norfolk Southern
NSC
$78.1B
| $5.42M | ﹤0.01% |
21,163
-2,268
| -10% | -$535K |
|
737
Denali Therapeutics
DNLI
$3.94B
| $5.41M | ﹤0.01% |
386,539
+94,744
| +32% | +$1.33M |
|
738
Universal Health Services
UHS
$10.2B
| $5.32M | ﹤0.01% |
29,388
-49
| -0.2% | -$8.84K |
|
739
KB Financial Group
KB
$42.6B
| $5.31M | ﹤0.01% |
64,244
+12,561
| +24% | +$849K |
|
|
EXE
740
Expand Energy Corp
EXE
$22.7B
| $5.3M | ﹤0.01% |
45,284
-5,024
| -10% | -$561K |
|
741
XPO
XPO
$22.4B
| $5.29M | ﹤0.01% |
41,895
-309,446
| -88% | -$34.7M |
|
742
Molina Healthcare
MOH
$10.4B
| $5.25M | ﹤0.01% |
17,611
-355
| -2% | -$111K |
|
743
Edison International
EIX
$28.4B
| $5.19M | ﹤0.01% |
100,487
-56,409
| -36% | -$3.09M |
|
744
Apogee Therapeutics
APGE
$10.2B
| $5.18M | ﹤0.01% |
119,246
+22,254
| +23% | +$847K |
|
745
Targa Resources
TRGP
$62B
| $5.12M | ﹤0.01% |
29,420
+3,403
| +13% | +$572K |
|
746
BioMarin Pharmaceuticals
BMRN
$12.6B
| $5.07M | ﹤0.01% |
92,281
-75,799
| -45% | -$4.46M |
|
747
Dr. Reddy's Laboratories
RDY
$10.1B
| $4.96M | ﹤0.01% |
329,939
+32,617
| +11% | +$466K |
|
748
Kontoor Brands
KTB
$4.18B
| $4.91M | ﹤0.01% |
+74,388
| New | +$4.81M |
|
749
H&R Block
HRB
$6.47B
| $4.86M | ﹤0.01% |
88,576
-5,773
| -6% | -$333K |
|
750
Kymera Therapeutics
KYMR
$10B
| $4.81M | ﹤0.01% |
110,213
-48,125
| -30% | -$1.66M |
|
Similar funds
Schroder Investment Management Group's Q2 2025 Portfolio in Review
As of Q2 2025, Schroder Investment Management Group held 1,252 positions worth $118B, up 19% from $99.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Schroder Investment Management Group deployed $6.2B of net new capital in Q2 2025, opening 68 new positions and adding to 498 existing holdings. Its largest new stake was XP: 7,047,885 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $474M trimmed.
- Schroder Investment Management Group's largest Q2 2025 buy was XP: 7,047,885 shares worth $142M.
- Schroder Investment Management Group added most to Microsoft in Q2 2025, an estimated $961M increase.
- Schroder Investment Management Group's biggest Q2 2025 reduction was Trip.com Group, cutting an estimated $474M.
- Schroder Investment Management Group fully exited Barrick Mining in Q2 2025, selling an estimated $43.9M.
- Schroder Investment Management Group's ten largest holdings make up 31% of its $118B portfolio in Q2 2025.
- Schroder Investment Management Group opened 68 new positions and closed 100 in Q2 2025.
- Schroder Investment Management Group's portfolio value rose 19% quarter-over-quarter to $118B.
Based on Schroder Investment Management Group's 13F filing for Q2 2025, filed 13 Aug 2025.